91081-0 |
Candida sp DNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Candida sp DNA [Presence] in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91081-0 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Candida DNA Spec Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; Monilia; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; species; spp; Strand Displacement Amplification; Thrush; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.69 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91082-8 |
Fungal 18S rRNA gene |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Fungal 18s rRNA gene [Presence] in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91082-8 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Fungal 18s rRNA gene Spec Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; rDNA; ribosomal RNA; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.69 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91083-6 |
Fungal 18S rRNA gene |
PrThr |
Isolate |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Fungal 18s rRNA gene [Presence] in Isolate by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91083-6 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Fungal 18s rRNA gene Islt Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; rDNA; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91084-4 |
Fungal 18S rRNA gene |
PrThr |
Hair/Nail/Skin |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Fungal 18s rRNA gene [Presence] in Dermatologic specimen by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91084-4 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Fungal 18s rRNA gene Derm Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Derm spec; Dermatologic; DNA NUCLEIC ACID PROBE; DNA probe; Epidermis; Gen-Probe; Har; ID; Infectious Disease; InfectiousDisease; Integument; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; Nails; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; rDNA; ribosomal RNA; Screen; SDA; Skn; Strand Displacement Amplification; TMA; Transcription mediated amplification; Ungal nail |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91085-1 |
Fungal 18S rRNA gene |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Fungal 18s rRNA gene [Presence] in Lower respiratory specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91085-1 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Fungal 18s rRNA gene L. Resp Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; rDNA; ribosomal RNA; RS; Screen; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.77 |
2.65 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
91086-9 |
Fungal BT2 gene |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Fungal BT2 gene [Presence] in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91086-9 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Fungal BT2 gene Spec Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.69 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91087-7 |
Fungal BT2 gene |
PrThr |
Isolate |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Fungal BT2 gene [Presence] in Isolate by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91087-7 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Fungal BT2 gene Islt Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91088-5 |
Fungal BT2 gene |
PrThr |
Hair/Nail/Skin |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Fungal BT2 gene [Presence] in Dermatologic specimen by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91088-5 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Fungal BT2 gene Derm spec Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Derm spec; Dermatologic; DNA NUCLEIC ACID PROBE; DNA probe; Epidermis; Har; ID; Infectious Disease; InfectiousDisease; Integument; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; Nails; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Skn; Strand Displacement Amplification; TMA; Transcription mediated amplification; Ungal nail |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91089-3 |
Fungal BT2 gene |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Fungal BT2 gene [Presence] in Lower respiratory specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91089-3 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Fungal BT2 gene Lower resp Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; RS; Screen; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.77 |
2.65 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
9109-0 |
Blood loss.total intraoperative |
Vol |
^Patient |
Procedure dur |
Qn |
Cell saver |
|
ACTIVE |
Blood loss.total intraoperative [Volume] Cell saver |
|
MIN |
DefinitionDescription |
|
|
mL |
|
|
|
|
|
|
IO_OUT.MOLEC |
|
9109-0 |
|
Cell saver |
|
|
|
|
|
|
0 |
Blood loss.total intraop Vol Cell Saver |
|
|
|
|
|
Bld loss; Blood output; EBL; IO_OUTPUT; IO_OUTPUT.MOLEC; QNT; Quan; Quant; Quantitative; Tot; Totl; Volume |
2.48 |
1.0i |
|
|
|
|
|
|
|
mL |
|
|
|
0 |
91090-1 |
Fungal ITS region |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Fungal ITS region [Presence] in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91090-1 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Fungal ITS region Spec Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.69 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91091-9 |
Fungal ITS region |
PrThr |
Isolate |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Fungal ITS region [Presence] in Isolate by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91091-9 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Fungal ITS region Islt Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91092-7 |
Fungal ITS region |
PrThr |
Hair/Nail/Skin |
Pt |
Ord |
Probe.amp.tar |
|
TRIAL |
Fungal ITS region [Presence] in Dermatologic specimen by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91092-7 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Fungal ITS region Derm spec Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Derm spec; Dermatologic; DNA NUCLEIC ACID PROBE; DNA probe; Epidermis; Har; ID; Infectious Disease; InfectiousDisease; Integument; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; Nails; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Skn; Strand Displacement Amplification; TMA; Transcription mediated amplification; Ungal nail |
2.65 |
2.65 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
91093-5 |
Fungal ITS region |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Fungal ITS region [Presence] in Lower respiratory specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91093-5 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Fungal ITS region Low Resp Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; RS; Screen; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.77 |
2.65 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
91094-3 |
Cause of deaths |
Find |
^Event |
Pt |
Nar |
|
|
ACTIVE |
Cause of deaths Narrative |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PUBLICHEALTH |
|
91094-3 |
|
|
|
|
Observation |
|
|
|
0 |
Cause of deaths |
|
|
|
|
|
Fatalities; Finding; Findings; Narrative; Point in time; Public Health; PUBLICHEALTH; Random; Report |
2.69 |
2.65 |
|
|
|
|
|
|
|
|
|
|
Release 2.69: COMPONENT: Updated "fatalities" to "deaths", the more commonly used term.; |
0 |
91095-0 |
Analysis of pharmaceutical needs in a region |
Find |
^Event |
Pt |
Nar |
|
|
ACTIVE |
Analysis of pharmaceutical needs in a region Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PUBLICHEALTH |
|
91095-0 |
|
|
|
|
Observation |
|
|
|
0 |
Analysis pharmaceut needs region |
|
|
|
|
|
Analysis pharmaceut needs region; Finding; Findings; Narrative; Point in time; Public Health; PUBLICHEALTH; Random; Report |
2.68 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91096-8 |
Countermeasure description |
Find |
^Event |
Pt |
Nar |
|
|
ACTIVE |
Countermeasure description Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PUBLICHEALTH |
|
91096-8 |
|
|
|
|
Observation |
|
|
|
0 |
Countermeasure description |
|
|
|
|
|
Finding; Findings; Narrative; Point in time; Public Health; PUBLICHEALTH; Random; Report |
2.68 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91097-6 |
Countermeasure implementation progress |
Find |
^Event |
Pt |
Nom |
|
|
ACTIVE |
Countermeasure implementation progress |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PUBLICHEALTH |
|
91097-6 |
|
|
|
|
Observation |
|
|
|
0 |
Countermeasure implementation |
|
|
|
|
|
Finding; Findings; Nominal; Point in time; Public Health; PUBLICHEALTH; Random |
2.66 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91098-4 |
Countermeasure name |
ID |
^Event |
Pt |
Nom |
|
|
ACTIVE |
Countermeasure name |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PUBLICHEALTH |
|
91098-4 |
|
|
|
|
Observation |
|
|
|
0 |
Countermeasure name |
|
|
|
|
|
Ident; Identifier; Nominal; Point in time; Public Health; PUBLICHEALTH; Random |
2.66 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91099-2 |
People tested |
Num |
^Population |
Pt |
Qn |
|
|
ACTIVE |
People tested [#] Population |
|
MIN |
DefinitionDescription |
|
|
# |
|
|
|
|
|
|
PUBLICHEALTH |
|
91099-2 |
|
|
|
|
Observation |
|
|
|
0 |
People tested Pop |
|
|
|
|
|
Cnt; Count; Number; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random |
2.68 |
2.65 |
|
|
|
|
|
|
|
{#} |
|
|
|
0 |
911-8 |
B Ab |
PrThr |
Ser/Plas^BPU |
Pt |
Ord |
|
|
ACTIVE |
B Ab [Presence] in Serum or Plasma from Blood product unit |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
911-8 |
|
|
|
|
Observation |
|
|
|
0 |
B Ab SerPl BPU Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPl^bpu; SerPlas; Serum; Serum or plasma; SR |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
9110-8 |
Blood loss.total intraoperative |
Vol |
^Patient |
Procedure dur |
Qn |
Estimated |
|
ACTIVE |
Blood loss.total intraoperative [Volume] Estimated |
|
MIN |
DefinitionDescription |
|
|
mL |
|
|
|
|
|
|
IO_OUT.MOLEC |
|
9110-8 |
|
Estimated |
|
|
|
|
|
|
0 |
Blood loss.total intraop Vol Est |
|
|
|
|
|
Bld loss; Blood output; EBL; Est; estimation; IO_OUTPUT; IO_OUTPUT.MOLEC; QNT; Quan; Quant; Quantitative; Tot; Totl; Volume |
2.48 |
1.0i |
|
|
|
|
|
|
|
mL |
|
|
|
0 |
91100-8 |
People with confirmed positive lab results |
Num |
^Population |
Pt |
Qn |
|
|
ACTIVE |
People with confirmed positive lab results [#] Population |
|
MIN |
DefinitionDescription |
|
|
# |
|
|
|
|
|
|
PUBLICHEALTH |
|
91100-8 |
|
|
|
|
Observation |
|
|
|
0 |
Confirmed positive lab results Pop |
|
|
|
|
|
Cnt; Count; Number; Point in time; Pos; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random |
2.68 |
2.65 |
|
|
|
|
|
|
|
{#} |
|
|
|
0 |
91101-6 |
People with preliminary positive lab results |
Num |
^Population |
Pt |
Qn |
|
|
ACTIVE |
People with preliminary positive lab results [#] Population |
|
MIN |
DefinitionDescription |
|
|
# |
|
|
|
|
|
|
PUBLICHEALTH |
|
91101-6 |
|
|
|
|
Observation |
|
|
|
0 |
Preliminary positive lab results Pop |
|
|
|
|
|
Cnt; Count; Number; Point in time; Pos; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random |
2.68 |
2.65 |
|
|
|
|
|
|
|
{#} |
|
|
|
0 |
91102-4 |
People with confirmed negative lab results |
Num |
^Population |
Pt |
Qn |
|
|
ACTIVE |
People with confirmed negative lab results [#] Population |
|
MIN |
DefinitionDescription |
|
|
# |
|
|
|
|
|
|
PUBLICHEALTH |
|
91102-4 |
|
|
|
|
Observation |
|
|
|
0 |
Confirmed negative lab results Pop |
|
|
|
|
|
Cnt; Count; NEG; Number; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random |
2.68 |
2.65 |
|
|
|
|
|
|
|
{#} |
|
|
|
0 |